Investigational biologic appears to reduce oral corticosteroid use in severe asthma

by | May 23, 2017 | Asthma in the News | 0 comments

An investigational biologic may reduce the need for adults with severe asthma to take an oral corticosteroid to control their asthma, according to a randomized controlled trial.

Submit a Comment

Your email address will not be published. Required fields are marked *